Developing steroidal aromatase inhibitors-an effective armament to win the battle against breast cancer

Eur J Med Chem. 2015 Nov 13:105:1-38. doi: 10.1016/j.ejmech.2015.09.038. Epub 2015 Oct 3.

Abstract

Breast cancer, an emerging disease among the women population, occurs due to overexpression of estrogens. The enzyme aromatase plays a key rate limiting role in the biosynthesis of estrogens. Certain clinical advantages of the use of exemestane, a steroidal aromatase inhibitor over non-steroidal aromatase inhibitors have drawn the attention of researchers for the development of novel steroidal aromatase inhibitors.The current review is a humble attempt to compile the reports by various researchers till date on the synthesis of steroidal aromatase inhibitors. It has been tried to encompass the structural modifications carried out by various researchers in the steroid ring system by taking up the functional group modifications on rings A, B, ring A/B junction, ring-D, ring modifications, bridged derivatives and heterocyclic ring-fused derivatives in a systematic way.

Keywords: Aromatase inhibitors; Breast cancer; Medicinal chemistry; Molecular modeling; Ring substituted androstanes; Steroids.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aromatase / metabolism*
  • Aromatase Inhibitors / chemical synthesis
  • Aromatase Inhibitors / chemistry
  • Aromatase Inhibitors / pharmacology*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / enzymology*
  • Drug Design*
  • Female
  • Humans
  • Models, Molecular
  • Molecular Structure

Substances

  • Aromatase Inhibitors
  • Aromatase